Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence
Autor:
Moreno-Torres, Víctor
; Soriano, Vicente
Fecha:
2023Palabra clave:
Revista / editorial:
Support UsContactAdmin QJM: An International Journal of MedicineCitación:
V Moreno-Torres , V Soriano, Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence, QJM: An International Journal of Medicine, 2023;, hcad100, https://doi.org/10.1093/qjmed/hcad100Tipo de Ítem:
Articulo Revista IndexadaResumen:
[Abstract not available]
Ficheros en el ítem
Nombre: Response_to_Prognostic_factors_in_hospitalized_HIV_positive_patients_with_COVID_19.pdf
Tamaño: 221.7Kb
Formato: application/pdf
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
36 |
50 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
52 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study
Moreno-Torres, Víctor; Soriano, Vicente; Calderon-Parra, Jorge; Martinez-Urbistondo, Maria; Treviño, Ana; de San Vicente, Zayrho; de Mendoza, Carmen; Ruiz-Irastorza, Guillermo (Autoimmunity Reviews, 2023)INTRODUCTION: SARS-CoV-2 infection and COVID-19 vaccines might have increased the incidence of giant-cell arteritis (GCA) and the risk of associated stroke in Spain. METHODS: Retrospective nation-wide observational ... -
Pre-Exposure Prophylaxis for viral infections other than HIV
Soriano, Vicente; Treviño, Ana; de Mendoza, Carmen; Moreno-Torres, Víctor; Pintos, Ilduara; Barreiro, Pablo; Corral, Octavio Jorge (Infezioni in Medicina, 2022)The battle against human viral infections has histori-cally relied on two medical strategies, namely vaccines to protect from contagion and antivirals to treat infected patients. In the absence of vaccines, antivirals have ... -
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
Soriano, Vicente; Moreno-Torres, Víctor; Treviño, Ana; Corral, Octavio Jorge; de Mendoza, Carmen (Drug Design, Development and Therapy, 2023)It has been ten years since the identification of NTCP as the cell surface receptor for HBV and HDV entry into hepatocytes. The search for molecules interfering with the binding of NTCP and HBV/HDV led to design bulevirtide ...